Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DYRK family comprises a group of protein kinases known for their ability to phosphorylate both serine/threonine and tyrosine residues. This dual specificity is unique. The family is evolutionarily conserved and involved in various cellular processes, including cell proliferation, development, DNA damage response, and gene expression. DYRK genes have notable clinical relevance, with DYRK1A implicated in Down syndrome and autism spectrum disorder. Inhibitors targeting one or more family members are being explored therapeutically for diseases where increased kinase activity contributes to pathology.
Kinase inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase Family (DYRK).